杨叶，中共党员，高级实验师。一直从事公共卫生实践教学工作，主持和参与各类教学改革课题9项，以通讯/第一作者发表教学改革论文4篇；开展膳食因子干预消化系统肿瘤发生发展机制研究，主持国家自然科学基金1项，南京医科大学科技发展基金项目1项，主要参与国家/省级各类研究课题13项，以通讯/第一（含共同）作者发表SCI论文10篇，获得国家发明专利2项，获得江苏省科学技术三等奖1项，江苏医学科技奖1项，南京市第十二届自然科学优秀学术论文二等奖1项。
代表性论文：
1. Yang Ye, Jin, Ming, Meng, Yajie, Dai, Yi, Chen, Shuai, Zhou, Yan, Li Yuan, Tang, Liming. Involvement and targeted intervention of benzo(a)pyrene-regulated apoptosis related proteome modification and muti-drug resistance in hepatocellular carcinoma. Cell Death & Disease. 2023, 14:256.(IF:9.685)
2. Ming Jin, Ye Yang (co-first author), Yi Dai, Rong Cai, Liunan Wu, Yuwen Jiao, Zhan Zhang, Haojun Yang, Yan Zhou, Liming Tang, Lei Li, Yuan Li. 27-Hydroxycholesterol is a specific factor in the neoplastic microenvironment of HCC that causes MDR via GRP75 regulation of the redox balance and metabolic reprogramming. Cell Biol Toxicol. 2021, epub ahead of print, DOI: 10.1007/s10565-021-09607-y (IF: 6.691).
3. Yongxin Qiu, Wenqi Shan, Ye Yang (Co-First author), Ming Jin, Yi Dai, Hanyu Yang, Ruonan Jiao, Yunwei Xia, Qinqiang Liu, Liang Ju, Guangming Huang, Jianping Zhang, Lihua Yang, Lei Li, and Yuan Li. Reversal of sorafenib resistance in hepatocellular carcinoma: epigenetically regulated disruption of 14-3-3η/hypoxia inducible factor-1α. Cell Death Discovery. 2019, 5: 120.
4. Ming Lu, Yi Dai, Miao Xu, Chi Zhang, Yuhong Ma, Ping Gao, Mengying Teng, Kailin Jiao, Guangming Huang, Jianping Zhang, Ye Yang (Corresponding author), and Zhiping Chu. The Attenuation of 14-3-3ζ is Involved in the Caffeic Acid-Blocked Lipopolysaccharide- Stimulated Inflammatory Response in RAW264.7 Macrophages. Inflammation. 2017, 40(5): 1753-1760.
5. Jian Shen, Fei Jiang, Ye Yang (Co-first author), Guangming Huang, Fuxing Pu, Qinqiang Liu, Lijun Chen, Liang Ju, Ming Lu, Fei Zhou, Chi Zhang, Xiagang Luo, Xiaojun Yang, Chengyu Jiao, Xiangcheng Li, Zhong Li, Yuan Li, Jianping Zhang. 14-3-3g is a novel growth-promoting and angiogenic factor in hepatocellular carcinoma. J Hepatol. 2016, 65: 953-962.